Generic Name |
||
---|---|---|
IND |
PT2977 | |
Brand Name (US) |
||
Manufacturer |
Peloton | |
Drug Type |
HIF-2a inhibitor | |
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
Reverse hypoxia | |
Strategy |
Modify tumor microenvironment | |
Drug Category |
SDH-directed |
Links |
|
|
PT2977 Poster from Peloton |
Trials of this drug |
|
|
A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors |
Trial results |